Log in
Enquire now
Intellia Therapeutics

Intellia Therapeutics

Intellia Therapeutics is a biotechnology company founded in 2014, based in Cambridge, MA that develops biopharmaceuticals using CRISPR-Cas9 gene editing technology.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/intellia-t...rapeutics-2
B2X
B2B
B2B
Board of Directors
‌
Frank Verwiel
0
Jean-Francois Formela
Jean-Francois Formela
0
John Leonard
John Leonard
0
‌
Caroline Dorsa
0
‌
John F. Crowley
0
‌
Georgia Keresty
0
‌
Muna Bhanji
0
‌
Fred Cohen
0
‌
Jesse Goodman
0
CEO
John Leonard
John Leonard
0
CFO
‌
Glenn Goddart
CIK Number
1,652,130
Legal Name
Intellia Therapeutics, Inc.
Company Operating Status
Active
Competitors
Sangamo Therapeutics
Sangamo Therapeutics
Voyager Therapeutics
Voyager Therapeutics
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...apeutics
CTO
‌
Eliana Clark
Date Incorporated
May 7, 2014
Email Address
marissa.igo@intelliatx.com
0
ian.karp@intelliatx.com
0
media@intelliatx.com
0
lina.li@intelliatx.com
0
Facebook URL
@pages/Intellia-Therapeutics/133289660562078
Founded Date
2014
Founder
Rachel Haurwitz
Rachel Haurwitz
Andy May
Andy May
0
Jennifer Doudna
Jennifer Doudna
Rodolphe Barrangou
Rodolphe Barrangou
0
‌
Nessan Bermingham
0
‌
Luciano Marraffini
Full Address
40 Erie Street Cambridge, MA 02139 United States
Headquarters
United States
United States
Industry
Biotechnology
Biotechnology
Biopharmaceutical
Biopharmaceutical
Therapeutics
Therapeutics
Genetic engineering
Genetic engineering
Cell therapy
Cell therapy
Immunotherapy
Immunotherapy
Cancer immunotherapy
Cancer immunotherapy
Oncology
Oncology
Healthcare
Healthcare
CRISPR
CRISPR
•••
Instagram URL
instagram.com/intellia...apeutics/
Invested in
Kyverna Therapeutics
Kyverna Therapeutics
Investors
Atlas Ventures
Atlas Ventures
Sectoral Asset Management
Sectoral Asset Management
OrbiMed
OrbiMed
Caribou Biosciences
Caribou Biosciences
Foresite Capital
Foresite Capital
Atlas Venture
Atlas Venture
Janus Capital Group
Janus Capital Group
EcoR1 Capital
EcoR1 Capital
Novartis
Novartis
Fidelity Investments
Fidelity Investments
Latest Funding Round Date
September 2015
Latest Funding Type
Series B
Series B
Legal classification
Corporation
Corporation
Public limited company
Public limited company
LinkedIn URL
@company/intellia-therapeutics-inc-
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
United States
United States
Number of Employees (Ranges)
501 – 1,000
0
Patents Assigned (Count)
1
Phone Number
+15188172176
0
+18574494175
0
+18577061612
0
Pitchbook URL
pitchbook.com/profiles.../99583-30
Exchange
Nasdaq
Nasdaq
0
Stock Symbol
NTLA
0
Technologies Used
CRISPR-Cas9
CRISPR-Cas9
CRISPR
CRISPR
Total Funding Amount (USD)
85,000,000
Twitter URL
@intelliatweets
Official Website
intelliatx.com
Wellfound ID
intellia-therapeutics-2
Wikidata ID
Q54621387

Find more companies like Intellia Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.